Stock Events

Cellavision AB 

€23.2
9
+€0.3+1.31% Today

Statistics

Day High
23.2
Day Low
23.05
52W High
-
52W Low
-
Volume
110
Avg. Volume
-
Mkt Cap
541.93M
P/E Ratio
42.88
Dividend Yield
0.84%
Dividend
0.19

Upcoming

Dividends

0.84%Dividend Yield
10Y Growth
10.6%
5Y Growth
6.03%
3Y Growth
32.7%
1Y Growth
-5.79%

Earnings

19JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
0
0.57
1.14
1.71
Expected EPS
1.7111004288781437
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow C26.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap8.06B
Bio-Rad Laboratories offers digital imaging systems in clinical diagnostics, competing in the digital cell morphology space with Cellavision.
Danaher
DHR
Mkt Cap188.85B
Danaher, through its subsidiaries like Beckman Coulter, provides hematology analyzers and related laboratory equipment, directly competing with Cellavision's digital microscopy and image analysis technologies.
Bruker
BRKR
Mkt Cap9.38B
Bruker Corporation offers microscopy and diagnostic solutions that overlap with Cellavision's digital cell imaging and analysis market.
Hologic
HOLX
Mkt Cap16.75B
Hologic provides diagnostic products and digital imaging systems that serve similar markets as Cellavision, particularly in cytology and pathology.
Agilon Health
AGL
Mkt Cap2.84B
Agilent Technologies offers a range of analytical instruments, including cell analysis solutions that compete with Cellavision's digital microscopy in the life sciences and diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap215.52B
Thermo Fisher Scientific offers a broad range of analytical and diagnostic equipment, including cell imaging systems that compete with Cellavision's offerings.
Resmed
RMD
Mkt Cap30.24B
ResMed, while primarily focused on sleep and respiratory markets, has ventured into health informatics and diagnostic software that could indirectly compete with Cellavision's digital analysis tools.
Illumina
ILMN
Mkt Cap17.3B
Illumina, known for its genetic variation and function systems, also offers imaging and analysis solutions that could compete with Cellavision in genomics and pathology markets.
Guardant Health
GH
Mkt Cap3.7B
Guardant Health, primarily focused on liquid biopsy, also develops digital and analytical tools for cancer diagnostics, potentially competing with Cellavision's imaging and analysis technologies.

About

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Proficiency Software, a web-based software designed to help laboratory managers assess, monitor, and promote staff competency in cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. Further, the company offers reagents to identify cell and tissue morphology, parasites, and bacteria in diagnosing various diseases; and instruments, including RAL SmearBox, RAL Stainbox, and RAL Stainer. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.
Show more...
CEO
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
Employees
223
Country
SE
ISIN
SE0000683484
WKN
000A0NEVD

Listings